Journal
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Volume 47, Issue 3, Pages 513-530Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2021.04.012
Keywords
Lupus; Treatment target; Lupus low disease activity state; Lupus nephritis; Mycophenolate; Euro-lupus; Anifrolumab; Belimumab